Correlation Between Nrgene Technologies and Medivie Therapeutic
Can any of the company-specific risk be diversified away by investing in both Nrgene Technologies and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nrgene Technologies and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nrgene Technologies and Medivie Therapeutic, you can compare the effects of market volatilities on Nrgene Technologies and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nrgene Technologies with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nrgene Technologies and Medivie Therapeutic.
Diversification Opportunities for Nrgene Technologies and Medivie Therapeutic
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Nrgene and Medivie is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Nrgene Technologies and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and Nrgene Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nrgene Technologies are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of Nrgene Technologies i.e., Nrgene Technologies and Medivie Therapeutic go up and down completely randomly.
Pair Corralation between Nrgene Technologies and Medivie Therapeutic
Assuming the 90 days trading horizon Nrgene Technologies is expected to generate 0.79 times more return on investment than Medivie Therapeutic. However, Nrgene Technologies is 1.27 times less risky than Medivie Therapeutic. It trades about 0.32 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about -0.29 per unit of risk. If you would invest 29,100 in Nrgene Technologies on September 1, 2024 and sell it today you would earn a total of 7,440 from holding Nrgene Technologies or generate 25.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 94.44% |
| Values | Daily Returns |
Nrgene Technologies vs. Medivie Therapeutic
Performance |
| Timeline |
| Nrgene Technologies |
| Medivie Therapeutic |
Nrgene Technologies and Medivie Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nrgene Technologies and Medivie Therapeutic
The main advantage of trading using opposite Nrgene Technologies and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nrgene Technologies position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.The idea behind Nrgene Technologies and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Medivie Therapeutic vs. Homebiogas | Medivie Therapeutic vs. Oron Group Investments | Medivie Therapeutic vs. Hiron Trade Investments Industrial | Medivie Therapeutic vs. Amir Marketing and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |